Seeking Alpha

HZNP
  Horizon Pharma - NASDAQ

9/22/2014, 8:29 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
HZNP vs. ETF Alternatives
Company Description
Horizon Pharma Inc is a specialty pharmaceutical company. It has developed and is commercializing DUEXIS, VIMOVO and RAYOS/LODOTRA, each of which targets unmet therapeutic needs in arthritis, pain and inflammatory diseases.
Sector: Healthcare
Industry: Biotechnology
Country: United States